9 Meters collaborates with NYU Langone Health to evaluate NM-102 for autoimmune disorder March 3, 2022
Grant supports Emergex's development of synthetic T-cell vaccine candidate for Chikungunya virus Feb. 22, 2022
Broadly neutralizing HCV antibodies isolated from high responders used to design new antibody Feb. 18, 2022